Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oxytocin And Uterotonic Agent Use For Cesarean Delivery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Lawrence Ching Tsen, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT01549223
First received: March 3, 2012
Last updated: January 2, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)